Processing

Evonik expands API and advanced intermediates manufacturing with €36m investment

The extension has included an addition or enhancement of a series of advanced technologies at contract manufacturing organization (CMO) Evonik’s production sites. The technologies include: high-potency active pharmaceutical ingredient (HPAPI), fermentation, methoxy polyethylene glycol (mPEGs) and continuous processing. Jean-Luc Herbeaux, senior vice president at Evonik, told us that the number Czytaj więcej…